Tag Archives: Gérrard Eddy Jai Poinern

Murdoch University (Australia) encourages* bone formation in sheep

It’s time to finally publish this which has been languishing in drafts folder: from a Sept. 16, 2014 news item on Nanowerk (Note: A link has been removed),

Murdoch University [Australia] nanotechnology researchers have successfully engineered synthetic materials which encouraged bone formation in sheep (“The synthesis, characterisation and in vivo study of a bioceramic for potential tissue regeneration applications”).

The advancement means the successful use of synthetic materials in bone grafts for human patients is a step closer. The material could also have potential future applications in fracture repair and reconstructive surgery.

A Sept. 16, 2014 Murdoch University news release, which originated the news item, notes

Currently the patient’s own bone, donated bone or artificial materials are used for bone grafts but limitations with all these options have prompted researchers to investigate how synthetic materials can be enhanced.

Dr Eddy Poinern and his team from the Murdoch Applied Nanotechnology Research Group worked with powdered forms of the bio ceramic hydroxyapatite (HAP) to form pellets with a sponge-like structure which were then successfully implanted behind the shoulders of four sheep by collaborators from the School of Veterinary and Life Sciences at Murdoch University.

HAP is already being used in a number of biomedical applications such as bone augmentation in dentistry because of its similarity to the inorganic mineral component of human bone. But treatments of HAP so that it can be successfully used in a bone graft have yet to be developed because of the complexities involved with compatibility and HAP’s load bearing limitations.

The news release goes on to provide a few technical details,

Dr Poinern and his team prepared pellets with varying density and porosity using a variety of chemical methods including sintering, ultrasound and microwaves. Four pellets were implanted into muscles in each of the sheep, later demonstrating good bio-compatibility, including mixed cell colonisation after four weeks and even new bone formation 12 weeks after the surgery.

“Using synthetic materials in this way is difficult and complicated because they need to be engineered to be porous and to replicate the various physical, chemical and mechanical properties found in natural bone tissue,” explained Dr Poinern.

“They also need to be non-toxic and have a degradation rate which will allow for cells from the host to steadily recolonize the area and permit the formation of blood vessels necessary for the delivery of nutrients to the forming bone tissues.

“We already knew that synthetic HAP was a good material to study for possible use in bone-related medicine, but we needed to find out if the pellets we’d engineered were bio-compatible.

“Our results were very positive – our pellets acted as a scaffold for the growth of bone material, made possible because of its porous properties allowing cells to infiltrate.

“The pellets were also very cost effective to make.”

Although the study was small scale and originally intended to test the bio-compatibility of the HAP pellets, the bone growth was beyond what the interdisciplinary team expected.

Associate Professor Martin Cake, who surgically implanted the pellets into the sheep, described the results as “stunning” and said they boded well for the use of engineered HAP in bone implants.

“This material begins as a powder that can be theoretically moulded to any shape, or perhaps one day even 3D printed, then sintered to harden it,” he said.

Dr Poinern said he was hoping to improve and match the physical and mechanical properties of the pellets with those of natural bone tissue in a new study.

“Once these properties have been achieved, further implantation studies will be carried out to establish the feasibility of using this scaffold for bone grafts,” he said.

Here’s a link to and a citation for the paper,

The synthesis, characterisation and in vivo study of a bioceramic for potential tissue regeneration applications by Gérrard Eddy Jai Poinern, Ravi Krishna Brundavanam, Xuan Thi Le, Philip K. Nicholls, Martin A. Cake, & Derek Fawcett. Scientific Reports 4, Article number: 6235 doi:10.1038/srep06235 Published 29 August 2014

This paper is open access.

This news release included information of a type I haven’t previously seen included,

The implantation study was carried out in non pregnant Merino ewes with the approval of Murdoch University’s Animal Ethics Committee and all experiments were conducted in accordance with the Australian National Health and Medical Research Council’s (NHMRC) Code of Practice for the care and use of animals for scientific purposes.

In accordance with the ethical principles of the Code, the sheep were simultaneously used in an unrelated trial involving surgery of the stifle joints.

After the pellets were removed, the sheep were humanely euthanased.

I’m glad to see the information and hope more research groups follow suit.

One final note, Murdoch University, Eddy Poinern, and Dereck Fawcett have been mentioned here before in an Aug. 1, 2014 posting about ‘green’ chemistry involving eucalyptus leaves, and gold nanoparticles.

* ‘encourage’ corrected to ‘encourages’ on Oct. 7, 2014 at 1315 hours PDT.

Eucalyptus leaves and gold nanoparticles

An Aug. 1, 2013 news item on Nanowerk highlights some ‘green’ chemistry in Australia,

Murdoch University (Australia) researchers have developed a ‘green’ method to create antibacterial gold nanoparticles for potential use in the medical field with the help of common eucalyptus leaves (“Green biosynthesis of gold nanometre scale plates using the leaf extracts from an indigenous Australian plant Eucalyptus macrocarpa”)

The Aug. 1, 2013 Murdoch University news release, which originated the news item, provides more information from the lead researcher about the use of gold nanoparticles in the medical field and about the ‘eucalyptus leaf’ technique,

“Gold nanoparticles have proven to be very versatile across a range of treatments, including in the delivery of double-stranded DNA in the emerging gene therapy area,” Dr Poinern said.

“They can also be passively accumulated in tumours for thermal treatment therapies, where they are heated to damage and kill cancer cells.

“And studies have shown that cancer drugs bonded to the surface of gold nanoparticles can effectively target tumours, improving delivery and minimising treatment durations and the side effects of anticancer drugs.”

Dr Poinern [Dr Gérrard Eddy Poinern, Director of the Murdoch Applied Nanotechnology Research Group (MANRG)] said, however, that up until recently, the particles’ production had involved expensive chemical and physical processes that often used toxic materials with potential hazards such as environmental toxicity, cytotoxicity and carcinogenicity.

“Thanks to the Eucalyptus macrocarpa, we’re changing that. Our method is water-based, performed at room temperature and without the need for complex equipment and is clean and non-toxic,” he said.

The ‘green’ production of gold nanometre scale particles involves dissolving high purity gold wire into a mixture of nitric and hydrochloric acid to produce gold chloride.

The gold chloride is then mixed with a water-based solution of leaf extracts from the common Eucalyptus macrocarpa and allowed to synthesize at room temperature.

“Not only does this result in the creation of nanometre scale gold prisms, but the wax of the eucalypt leaf extract provides an additional antibacterial and antifungal quality,” Dr Poinern said.

“Since bacterial and fungal species have the ability to develop immunity against commonly used antibiotics over time, our gold nanometre scale particles also stand to be a new tool against antibiotic resistant forms of microorganisms.”

Dr Poinern said the nanometre scale gold particles were tested as antibacterial agents against both E. coli and B. subtilis, producing zone inhibition of 19mm and 16mm respectively.

Murdoch University has provided an image of eucalyptus leaves,

Eucalyptus macrocarpa is giving nano-medicine a boost

Eucalyptus macrocarpa is giving nano-medicine a boost

Here’s a link to and a citation for the published paper,

Green biosynthesis of gold nanometre scale plates using the leaf extracts from an indigenous Australian plant Eucalyptus macrocarpa by Gérrard Eddy Jai Poinern, Peter Chapman, Xuan Le, and Derek Fawcett. Gold Bulletin DOI: 10.1007/s13404-013-0096-7 Online ISSN 2190-7579

The paper is open access.

One final note, I trust the koala population is willing to share one of the mainstays of their diet.